Form4insider filings, from the source

SEC Form 4 · accession 0001144204-15-061891

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Oct 28, 2015P149,200$14.00A2,469,552ISee Footnote
Common StockF2,F1Oct 29, 2015P95,000$14.00A2,564,552ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses